UK markets open in 6 hours 45 minutes
NIKKEI 225
38,202.37 0.00 (0.00%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.30 +0.31 (+0.39%) GOLD FUTURES
2,315.90 -6.40 (-0.28%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,093.15 -935.13 (-1.87%)
REGENXBIO Inc. (RGNX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 16.96 |
| Open | 16.70 |
| Bid | 16.60 x 200 |
| Ask | 16.69 x 300 |
| Day's range | 16.20 - 17.35 |
| 52-week range | 11.83 - 28.80 |
| Volume | |
| Avg. volume | 697,109 |
| Market cap | 817.542M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.02 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 39.83 |
ZacksRegenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -7.81% and 37.77%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireREGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights
REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the first quarter ending March 31, 2024. Recent operational highlights, including acceleration of the prioritized pipeline supports meaningful value generation from the Company's strong portfolio of AAV Therapeutics.
- PR Newswire
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights
REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2024, and recent operational highlights.
© 2024 Yahoo. All rights reserved.